Chorus Labs Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 30-12-2024
- Paid Up Capital ₹ 9.70 Cr
as on 30-12-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.84 Cr
as on 30-12-2024
- Revenue -13.36%
(FY 2022)
- Profit -37.54%
(FY 2022)
- Ebitda -37.16%
(FY 2022)
- Net Worth 10.43%
(FY 2022)
- Total Assets 37.62%
(FY 2022)
About Chorus Labs
The Corporate was formerly known as Chorus Labs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.70 Cr.
The company currently has active open charges totaling ₹7.84 Cr.
The Key Managerial Personnel (KMP) at Chorus Labs Limited India is Kamal Naramsetty as COMPANY SECRETARY. Bollareddy Baby, Veerareddy Kondapally, Srivarsha Reddy, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239TG2005PLC046952
- Company No.
046952
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Jul 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Chorus Labs?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamal Naramsetty | Company Secretary | 11-Sep-2024 | Current |
Bollareddy Narasa  | Managing Director | 06-Mar-2009 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bollareddy Baby | Director | 06-Mar-2009 | Current |
| Veerareddy Kondapally | Additional Director | 12-Jun-2024 | Current |
| Srivarsha Reddy | Additional Director | 12-Jun-2024 | Current |
Financial Performance of Chorus Labs.
Chorus Labs Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 13.36% decrease. The company also saw a substantial fall in profitability, with a 37.54% decrease in profit. The company's net worth Soared by an impressive increase of 10.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chorus Labs?
In 2021, Chorus Labs had a promoter holding of 48.95% and a public holding of 51.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chorus Drugs Private LimitedActive 16 years 2 monthsBollareddy Baby and Bollareddy Narasa are mutual person
Charges (Loans)
₹7.84 Cr
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 7.84 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Aug 2009 | State Bank Of India | ₹4.90 Cr | Open |
| 08 May 2006 | State Bank Of India | ₹2.94 Cr | Open |
How Many Employees Work at Chorus Labs?
Chorus Labs has a workforce of 28 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chorus Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chorus Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
